Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Stirling Pharma has received Site License from the Health Canada's Minister of Health under the authority of the Natural Health Products Regulations for the manufacturing, packaging and labelling of natural health products at its manufacturing facility located in North Sydney, Nova Scotia.
Subscribe to our email newsletter
Furthermore, Health Canada has advised that an inspection for the issue of an Establishment License has been scheduled over a number of days commencing 29 November 2010, following which a full Establishment License is expected to issue that will then allow Stirling Pharma to manufacture pharmaceutical drugs.
Stirling Pharma’s 46,000 sqft Cape Breton high-tech GMP pharmaceutical plant includes laboratories for formulation development and includes specialist sections having various capabilities such as high shear mixing, container blending and equipment for the manufacture of modified drug release product.
Stirling Pharma claimed that the facility provides formulation development and testing services, as well as provision for the manufacture and packaging of products in solid and liquid dosage forms.